Stablecon Sep 2025 a Series of CGF2021 LLC (CIK: 0002093557) EDGAR, Information, Filings... CompaniesBIO.Com

Stablecon Sep 2025 a Series of CGF2021 LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Stablecon Sep 2025 a Series of CGF2021 LLC (CIK: 0002093557) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. Stablecon Sep 2025 a Series of CGF2021 LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Stablecon Sep 2025 a Series of CGF2021 LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002093557-25-000001 (33 Act) Size: KB	Oct-24-2025	021-562019 251415518

Recent 20 filings. View all Stablecon Sep 2025 a Series of CGF2021 LLC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Stablecon Sep 2025 a Series of CGF2021 LLC overview
Stablecon Sep 2025 a Series of CGF2021 LLC job
Stablecon Sep 2025 a Series of CGF2021 LLC stock
Stablecon Sep 2025 a Series of CGF2021 LLC ownership
Stablecon Sep 2025 a Series of CGF2021 LLC CEO
Stablecon Sep 2025 a Series of CGF2021 LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.